Close Menu

apoptosis

The company will use the microkinetic test to measure apoptosis and draft a therapeutic profile for chemotherapy.

The companies collaborated to offer a screening method using their microplate and cell-based assay tools.

Having site-specifically labeled human annexin V, the two companies are now developing an imaging biomarker to evaluate responses to anti-inflammatory and oncology therapies.

Papers of Note for Feb 2009

Premium

RNAi-Related Papers Published Feb. 2009

Genentech developed Unison to reduce the amount of time researchers spent on data preparation prior to bioinformatics analysis. Recognizing that many scientists outside the company are grappling with the same issues, they decided to release the system under the open-source Academic Free License.

The initiative, which began in 2005, now has 37 members.

As part of the arrangement, Columbia and the University of Nebraska-Lincoln signed an inter-institutional agreement that makes Columbia the lead on patent prosecution and negotiations, but gives both universities and their faculty inventors an undisclosed equity stake in the company.

Taking vitamin E, selenium, or both for several weeks before having a prostatectomy can alter gene expression in prostate cancer biopsy samples.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.